Home » Pfizer to Help Manufacture Remdesivir at Kansas Facility
Pfizer to Help Manufacture Remdesivir at Kansas Facility
Pfizer has entered into a multi-year agreement with Gilead Sciences to manufacture Gilead’s remdesivir at its facility in McPherson, Kansas.
California-based Gilead is scaling up production of the antiviral for the treatment of COVID-19, using a manufacturing network that includes more than 40 companies in North America, Europe and Asia.
Responding to concerns from advocacy groups about a possible shortage of the drug, Gilead said it will be able to make enough remdesivir to meet global demand in October.
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
21Oct